Activation of BNIP3-mediated mitophagy protects against renal ischemia-reperfusion injury by Tang, Chengyuan et al.
Tang et al. Cell Death and Disease          (2019) 10:677 
https://doi.org/10.1038/s41419-019-1899-0 Cell Death & Disease
ART ICLE Open Ac ce s s
Activation of BNIP3-mediated mitophagy protects
against renal ischemia–reperfusion injury
Chengyuan Tang1, Hailong Han2, Zhiwen Liu1, Yuxue Liu1, Lijun Yin1, Juan Cai1, Liyu He1, Yu Liu1, Guochun Chen1,
Zhuohua Zhang2, Xiao-Ming Yin3 and Zheng Dong1
Abstract
Acute kidney injury (AKI) is a syndrome of abrupt loss of renal functions. The underlying pathological mechanisms of
AKI remain largely unknown. BCL2-interacting protein 3 (BNIP3) has dual functions of regulating cell death and
mitophagy, but its pathophysiological role in AKI remains unclear. Here, we demonstrated an increase of BNIP3
expression in cultured renal proximal tubular epithelial cells following oxygen-glucose deprivation-reperfusion (OGD-
R) and in renal tubules after renal ischemia–reperfusion (IR)-induced injury in mice. Functionally, silencing Bnip3 by
speciﬁc short hairpin RNAs in cultured renal tubular cells reduced OGD-R-induced mitophagy, and potentiated OGD-R-
induced cell death. In vivo, Bnip3 knockout worsened renal IR injury, as manifested by more severe renal dysfunction
and tissue injury. We further showed that Bnip3 knockout reduced mitophagy, which resulted in the accumulation of
damaged mitochondria, increased production of reactive oxygen species, and enhanced cell death and inﬂammatory
response in kidneys following renal IR. Taken together, these ﬁndings suggest that BNIP3-mediated mitophagy has a
critical role in mitochondrial quality control and tubular cell survival during AKI.
Introduction
Acute kidney injury (AKI) is a clinical syndrome of
abrupt loss of renal functions that is pathologically fea-
tured by sublethal and lethal injury of renal tubules. The
clinical risk factors for AKI mainly include renal
ischemia–reperfusion (IR), nephrotoxins, and sepsis. AKI
has poor short- and long-term outcome. Besides its high
short-term mortality, AKI has been recently recognized as
an important risk factor for the development of chronic
kidney disease (CKD)1,2. Recent experimental studies have
demonstrated that the pathogenesis of AKI is complex,
involving tubular, microvascular, and inﬂammatory
mechanisms, diverse signal pathways, and molecules3. Of
note, studies have highlighted a pivotal role of mitochon-
drial dysfunction in AKI development and progress4–9.
Targeting mitochondrial protection and timely removal of
damaged mitochondria have been proposed as promising
strategies to prevent, treat AKI, and impede AKI-CKD
transition10–13.
Mitophagy is a speciﬁc form of autophagy that selec-
tively degrades mitochondria. As a critical component of
mitochondrial quality control, mitophagy targets
damaged or dysfunctional mitochondria for prompt
elimination, thereby preventing excessive reactive oxygen
species (ROS) production, and release of mitochondrial
pro-apoptotic factors and damage-associated molecular
patterns (DAMPs) that may promote pathological
inﬂammatory responses6,14. Mechanistically, mitophagy
requires a coordinative induction of autophagy and
mitochondrial priming for autophagic recognition. Thus,
two mitochondrial priming mechanisms have been pro-
posed, which rely on PTEN-induced kinase 1 (PINK1)-
parkin RBR E3 ubiquitin protein ligase (PARK2) pathway
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and mitophagy receptors BCL2-interacting protein 3 like
(BNIP3L/NIX), BCL2-interacting protein 3 (BNIP3), or
FUN14 domain containing 115,16. Recent evidence from
other studies and our study suggests an involvement of
mitophagy in AKI pathogenesis17–21. However, its precise
roles and regulation in AKI remain not fully understood.
BNIP3 is a Bcl-2 family protein with an atypical BH3
domain that primarily localizes in mitochondrial out
membrane. BNIP3 was ﬁrstly identiﬁed as a pro-apoptotic
protein. Its induction has been shown to sensitize BAX
(BCL2-associated X, apoptosis regulator) and BAK (BCL2
antagonist/killer 1) insertion and activation in the mito-
chondria, a key step for mitochondrial outer membrane
permeabilization that results in the release of pro-
apoptotic factors in the inter-membrane mitochondrial
space into the cytosol to initiate apoptosis cascade22,23.
On the other hand, recent studies suggest that BNIP3 is
also a mitophagy receptor, and plays pro-survival roles in
some pathological conditions24–27. In kidney, emerging
evidence indicated that BNIP3 might have a role in the
regulation of mitophagy in cultured renal proximal tub-
ular cells (RPTCs) in response to oxidative stress and
hypoxia20, but its precise role in AKI pathogenesis
remains largely unknown. In the present study, we have
investigated the role of BNIP3 in the development of
ischemic AKI by using cultured RPTCs subjected to
oxygen-glucose deprivation and reoxygenation (OGD-R)
and a mouse model of renal IR injury as model systems.
The results support that BNIP3 is an important mediator
of mitophagy in renal tubular cells, and BNIP3-dependent
mitophagy plays a critical role in mitochondrial quality
control for tubular cell viability and function in AKI.
Results
Suppression of Bnip3 expression sensitizes BUPMT cells to
OGD-R injury in vitro
We ﬁrst evaluated the expression of BNIP3 in Boston
University mouse proximal tubule (BUMPT) cells that
were subjected to OGD-R to mimic in vivo IR. Immu-
noblotting analysis showed a dramatic increase of BNIP3
in BUMPT cells after OGD-R (Fig. 1b, c). Speciﬁc Bnip3-
short hairpin RNAs (shRNAs) dramatically reduced
BNIP3 expression (Fig. 1a, c). Terminal deoxynucleotidyl
transferase-mediated dUTP nick-end labeling (TUNEL)
assay demonstrated that Bnip3 knockdown (KD) showed
minimal effect on TUNEL labeling under controlled
condition, but dramatically increased the number of
TUNEL-positive cells after OGD-R (Fig. 1d, e). Con-
sistently, immunoblot of active/cleaved caspase-3
demonstrated that Bnip3 KD cells had a signiﬁcantly
higher level of activated caspase-3 than wild-type (WT)
cells after OGD-R (Fig. 1f, g). Taken together, these
ﬁndings support that BNIP3 silencing increases the sen-
sitivity of proximal tubular cells to OGD-R-induced
apoptosis, suggesting a pro-survival role of BNIP3 in
these cells.
Suppression of Bnip3 expression reduces OGD-R-induced
mitophagy in BUPMT cells
BNIP3 regulates both cell death and mitophagy. Our
above results showed pro-survival functions of BNIP3 in
BUPMT cells (Fig. 1d–g). We therefore focused on its
potential role in the regulation of mitophagy. Immuno-
blotting analysis showed a remarkable increase of autop-
hagosome marker microtubule-associated protein 1 light
chain 3β (MAP1LC3B/LC3B-II) and a decrease of speciﬁc
autophagy substrate sequestosome 1 (SQSTM1) in
BUPMT cells following OGD-R, indicating autophagy
activation (Fig. 2a–c). Moreover, the alterations in LC3B-
II and SQSTM1 were associated with a marked reduction
of mitochondrial membrane protein translocase of inner
mitochondrial membrane 23 (TIMM23) and translocase
of outer mitochondrial membrane 20 (TOMM20) (Fig. 2a,
d, e), suggesting an induction of mitophagy. Notably,
Bnip3 KD resulted in less LC3B-II accumulation, and
partially reduced the degradation of SQSTM1 as well as
TIMM23 and TOMM20 in BUMPT cells following OGD-
R (Fig. 2a–e). Collectively, these ﬁndings suggested an
important role of BNIP3 in the regulation of mitophagy in
BUPMT cells during OGD-R. To further verify the pro-
mitophagy function of BNIP3, we evaluated mitophago-
some formation by assessing the colocalization of mito-
chondria and autophagosomes. As shown in Fig. 2f, under
controlled condition, both WT and Bnip3 KD cells had
very few green ﬂuorescent protein (GFP)-LC3B puncta,
indicating a low level of autophagy. In the setting of
OGD-R, an increase of GFP-LC3B puncta occurred in
both WT and Bnip3 KD cells, and partial GFP-LC3B
puncta colocalized with the mitochondria (Fig. 2f), sug-
gesting the formation of mitophagosomes. Notably,
quantiﬁcation analysis showed that OGD-R induced
much less autophagosome and mitophagosome formation
in Bnip3-KD cells than in WT cells, suggesting an inhi-
bitory effect of Bnip3 KD on mitophagy (Fig. 2g, f). Taken
together, these results suggest a pro-mitophagy role of
BNIP3 in RPTCs.
Bnip3 deﬁciency exacerbates renal IR-induced kidney
injury in vivo
We then determined the role of BNIP3 in the patho-
genesis of ischemic AKI in vivo. We ﬁrst examined the
expression of BNIP3 in kidney tissues of mouse models
of ischemic AKI that was induced by 30 min of bilateral
kidney ischemia, followed by 48 h of reperfusion.
Immunohistochemical analysis showed that BNIP3 was
dramatically induced in cortical renal proximal tubules
of ischemic mice (Fig. 3a). Immunoblotting analysis
conﬁrmed the induction of BNIP3 in kidney tissues
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following renal IR (Fig. 3b, c). The above ﬁnding pro-
vided in vivo evidence for the induction of BNIP3 in
RPTCs in ischemic AKI. To verify the role of BNIP3 in
the pathogenesis of ischemic AKI, Bnip3-knockout (KO)
mice were applied (Fig. 3a, b). Histological examination
by hematoxylin and eosin (HE) staining showed that
both Bnip3-KO mice and their WT control littermates
had normal kidney structure under physiological condi-
tion, but showed obvious tubular injury in the setting of
renal IR (Fig. 3d). Quantitative analysis showed that KO
Fig. 1 Suppression of Bnip3 expression sensitizes BUMPT cells to OGD-R injury. a Representative immunoblot of BNIP3. For OGD-R treatment,
cells were subjected to 2 h OGD followed by 6 h reperfusion. Note: * indicated unspeciﬁc band. b Densitometry of BNIP3 signals in BUMPT cells with or
without OGD-R treatment (n= 3). The BNIP3 signals were normalized to the β-actin signal of the same samples to determine the ratios. c Related Bnip3
mRNA levels in BUMPT cells stably expressing scrambled (Scr) shRNA or Bnip3-shRNA (n= 3). The Bnip3 mRNA levels were normalized to the Gaphd
mRNA levels of the same sample to determine the rations. The ratios of control cells (Ctrl) were arbitrarily set as 1. d Representative images of TUNEL
assay. Bar: 100 μm. e Apoptosis percentage (n= 3). f Representative immunoblots of active caspase-3. Cells were subjected to 2 h OGD followed by
reperfusion for 10min, 6 h, or 9 h, and whole-cell lysates were collected for immunoblot of activated caspase-3 and β-actin. d Densitometry of active
caspase-3 (n= 3). The signal of cleaved caspase-3 was normalized to the β-actin signal of the same samples to determine the ratios. The ratios of
control cells (Ctrl) were arbitrarily set as 1. Each symbol (circle and diamond) represents an independent experiment. Error bars: SEM. **p < 0.01
Tang et al. Cell Death and Disease          (2019) 10:677 Page 3 of 15
Ofﬁcial journal of the Cell Death Differentiation Association
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mice had a signiﬁcantly higher renal tubular damage
score than WT mice after renal IR (Fig. 3e). In line with
the results of histological analysis, serum creatinine
concentration in both KO and WT mice was low and
comparable following sham operation (Fig. 3f), and was
dramatically increased in both mice after renal IR.
However, the concentration of serum creatinine in
ischemic KO was signiﬁcantly higher than in WT mice in
the same experimental setting (Fig. 3f), indicating more
severe renal failure in Bnip3-KO mice after renal IR.
Moreover, renal IR induced signiﬁcantly higher levels of
kidney injury molecule 1 (KIM1), a biomarker of AKI, in
Bnip3- KO mice than in WT mice (Fig. 3g, h).
The effect of Bnip3 deﬁciency on renal tubular cell
apoptosis was also evaluated by TUNEL assay and
staining of active cleaved caspase-3. As shown in Fig. 4a,
Bnip3-KO and WT kidneys had few TUNEL-positive
tubular cells following sham operation condition, and
both had an increase of the positive cells after renal IR.
Quantiﬁcation analysis demonstrated that there were
signiﬁcantly more TUNEL-labeled tubular cells in
Bnip3-KO kidneys than in WT kidneys after renal IR
(Fig. 4b). Consistently, staining and quantiﬁcation
analysis demonstrated that renal IR resulted in sig-
niﬁcantly more active caspase 3-positive tubular cells in
Bnip3-KO mice than in WT mice (Fig. 4c, d). Collec-
tively, these in vivo ﬁndings provided compelling evi-
dence supporting a renoprotective role of BNIP3 in
ischemic AKI.
Bnip3 deﬁciency increases renal inﬂammation after renal IR
Inﬂammation contributes critically to the initiation
and extension of AKI28. We therefore evaluated renal
inﬂammation by assessing renal inﬁltration of macro-
phages and neutrophils. As shown in Fig. 5a–c, renal IR-
induced macrophage and neutrophil inﬁltration into
kidneys in both Bnip3-KO and WT mice. Quantiﬁcation
analysis showed that ischemic Bnip3-KO mice had more
macrophages (Fig. 5b) and neutrophils (Fig. 5c) inﬁl-
trating the kidney than ischemic WT mice. Moreover,
quantitative real-time polymerase chain reaction (qRT-
PCR) analysis of the expression of proinﬂammatory
cytokines interleukin-1β (IL-1b) and tumor necrosis
factor-α (TNF-α) in kidney tissues demonstrated that
renal IR induced signiﬁcantly higher expression of these
cytokines in Bnip3-KO mice than in WT mice (Fig. 5d,
e). These results support that Bnip3-KO mice have
much stronger interstitial inﬂammation than WT mice
after renal IR.
Bnip3 deﬁciency accumulates damaged mitochondria and
increases ROS production following renal IR
We examined the effect of Bnip3 deﬁciency on mito-
chondrial integrity in RPTCs by transmission electron
microscopy (TEM) and morphometric analysis as pre-
viously described18,29. Under controlled condition, Bnip3-
KO and WT mice had tubular mitochondria in RPTCs
(Fig. 6a). After renal IR, WT mice had an increase of small
and round mitochondria, indicating mitochondrial frag-
mentation (Fig. 6a). Notably, loss of BNIP3 showed pro-
found effects on mitochondrial structure, including the
increase in mitochondrial fragmentation and swelling,
vacuoles in the mitochondrial matrix, and loss of cristae.
Quantiﬁcation analysis of abnormal mitochondria that
were swollen with evidence of severely disrupted cristae
revealed that renal IR resulted in signiﬁcantly more
damaged mitochondria in RPTCs in Bnip3-KO mice than
in WT mice (Fig. 6a, b). Collectively, these ﬁndings sug-
gest that loss of Bnip3 accumulates damaged mitochon-
dria in renal tubular cells following renal IR.
Mitochondrial damage and dysfunction are associated
with increased ROS production. Thus, we determined
ROS levels within kidney tissues by dihydroethidium
(DHE) staining. Under the condition of sham operation,
both WT and KO mice had similarly low intensity of DHE
signals in RPTCs (Fig. 6c). However, KO and WT kidneys
showed a dramatic increase in the DHE signals in RPTCs
after renal IR (Fig. 6c), and quantiﬁcation analysis
demonstrated that the KO mice had signiﬁcantly stronger
DHE signals than WT mice (Fig. 6d). These results of
(see ﬁgure on previous page)
Fig. 2 Suppression of Bnip3 expression reduces OGD-R-induced mitophagy in BUMPT cells. a Representative blots. BUMPT cells stably
expressing Scr-shRNA or Bnip3-shRNA were subjected to 2 h of OGD, followed by reperfusion for 6 or 9 h. Whole-cell lysates were collected for
immunoblot of LC3B-II, SQSTM1, TIMM23, TOMM20, and β-actin. b–e Densitometry of LC3B-II (b), SQSTM1 (c), TIMM23 (d), and TMOM20 (e) signals
(n= 3). For densitometry, the signals of the target proteins were normalized to the β-actin signal of the same samples to determine the ratios. The
ratios in sample of Scr-shRNA cells without OGD-R were arbitrarily set as 1 or 100% in each blot. f Representative images of autophagosome and
mitophagosome. Bar: 10 μm. BUMPT cells stably expressing Scr-shRNA or Bnip3-shRNA were transiently transfected with GFP-LC3B to label
autophagosome. At 24 h after transfection, cells were subjected to 2 h of OGD, followed by 6 h of reperfusion. Cells cultured in regular medium and
incubator were used as control. The cells were then ﬁxed and stained with primary antibody against TOMM20 and corresponding ﬂuorescent-labeled
secondary antibody to label mitochondria. Nuclei were stained with DAPI (blue). g Quantiﬁcation for LC3B puncta. The number of LC3B puncta in at
least 30 cells from three different experiments was counted to indicate autophagosome formation. h Quantiﬁcation for mitophagosome formation.
LC3B puncta colocalizing with mitochondria in at least 30 cells from three different experiments were counted to indicate mitophagosome
formation. Each symbol (circle and diamond) represents an independent experiment. Error bars: SEM, n= 3. *P < 0.05; **p < 0.01; ns not signiﬁcant
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DHE staining are in line with the ﬁndings of more accu-
mulation of damaged mitochondrial in RPTCs of Bnip3-
KO mice.
Bnip3 deﬁciency reduces renal IR-induced mitophagy
in vivo
The marked accumulation of damaged mitochondria in
RPTCs of ischemia-operated Bnip3-KO mice suggests
possibly defective mitochondrial elimination. Therefore,
we evaluated the effect of loss of Bnip3 on mitophagy in
kidneys. Immunoblotting analysis showed an increase of
LC3B-II and a concurrent decrease of SQSTM1 in WT
kidney tissues after renal IR (Fig. 7a–c), and their changes
were accompanied by a remarkable reduction of mito-
chondrial protein TIMM23 (Fig. 7a–d), suggesting mito-
phagy and mitochondrial clearance. Notably, the renal IR-
induced changes in LC3B-II, SQSTM1, and TIMM23 in
WT kidneys were partially but signiﬁcantly reversed in
ischemic Bnip3-KO kidney (Fig. 7a–d), suggesting an
inhibitory effect of loss of BNIP3 on mitophagy. We fur-
ther evaluated autophagosome and mitophagosome for-
mation by immunoﬂuorescence staining in kidney tissues
using primary antibody against LC3B and mitochondrial
protein cytochrome c oxidase subunit 4I1 (COX4I1/
COXIV), respectively, and corresponding ﬂuorescently
labeled secondary antibodies. As shown in Fig. 7e, LC3B
puncta were rarely observed in kidney tissues of sham-
operated mice regardless of Bnip3 status, but were dra-
matically increased in kidney tissue of ischemic Bnip3-KO
and WT mice. Of note, partial LC3B-labeled autophago-
somes colocalized with the mitochondria, indicating the
formation of mitophagosomes (Fig. 7e). Quantiﬁcation
analysis demonstrated that there was signiﬁcantly less
renal tubules with autophagosome and mitophagosome
formation in Bnip3-KO mice compared to WT mice after
renal IR (Fig. 7e–g), suggesting a reduction of mitophagy
under the condition of Bnip3 deﬁciency. Further exam-
ination by using TEM conﬁrmed autophagosome and
mitophagosome formation in tubular cells after renal IR
(Fig. 7h), which were rarely observed in kidney tissues
from sham-operated mice. Taken together, these ﬁndings
provide in vivo evidence that BNIP3 has a role in mito-
phagy regulation in renal tubular cells in ischemic AKI.
Discussion
The pathophysiological role of BNIP3 in AKI remains
unknown. In the present study, we have provided sub-
stantial evidence supporting a renoprotective role of
BNIP3 in renal tubular cells via regulating mitophagy. We
demonstrates that BNIP3 is upregulated in RPTCs in both
in vitro and in vivo models of ischemic AKI, and loss of
BNIP3 aggravates ischemic injury. We provide further
evidence that loss of BNIP3 reduces mitophagy, resulting
in the accumulation of damaged mitochondria and ROS,
increases of cell death, and enhancement inﬂammatory
response in kidneys following renal IR. Thus, these ﬁnd-
ings indicate that enhancement of mitophagy may repre-
sent a promising novel therapeutic approach for AKI.
Upregulation of BNIP3 in RPTCs has been implicated in
an experimental rat model of ischemic AKI20. However,
the pathophysiological role of BNIP3 in AKI pathogenesis
remains largely unknown. BNIP3 was initially identiﬁed as
a pro-death protein22, and its pro-death function has been
associated with the pathogenicity of cardiac diseases30–33.
For instance, in animal models of cardiac ischemia-
induced myocardial infarction, BNIP3 induction in ven-
tricular myocytes occurred during early cardiac ischemia
and persisted throughout reperfusion in an accompany
with mitochondrial dysfunction and cardiomyocyte
death32. More importantly, inhibition of BNIP3 activity by
gene deletion or expression of dominant-negative form of
BNIP3 dramatically reduced myocardial apoptosis and
myocardial injury after cardiac IR30,34, suggesting a
pathogenic role of BNIP3 induction in cardiac infarction.
On the other hand, emerging evidence also supports a
cytoprotective role of BNIP3 in some disease condi-
tions24–27. Our present study provides substantial evi-
dence supporting a renoprotective role of BNIP3 in
ischemic AKI, as evidenced by much more severe kidney
structural and functional damage (Fig. 3d–h), more tub-
ular cell death (Fig. 4), and stronger inﬂammation (Fig. 5)
in the kidney of Bnip3-KO mice compared to their WT
littermates after renal IR. The discrepancy concerning
BNIP3 function in different tissues may suggest cell-type-
speciﬁc functions of BNIP3. However, the underlying
determinants of the pro-survival or pro-death functions of
BNIP3 in different conditions remains poorly understood.
(see ﬁgure on previous page)
Fig. 3 Bnip3 deﬁciency exacerbates renal IR-induced kidney injury. Bnip3 deﬁciency (KO) mice and their wild-type littermates (WT) (male,
8 weeks old) were subjected to 30 min bilateral renal ischemia followed by 48 h of reperfusion (IR) or sham operation (sham). Kidney tissues were
collected for histological and biochemical analysis. a Representative images of BNIP3 staining. b Representative immunoblot of BNIP3. c
Densitometry of BNIP3 signals (n= 3). For densitometry, the BNIP3 signals were normalized to the cyclophilin B signal of the same samples to
determine the ratios. d Representative images of hematoxylin–eosin staining. Bar: 100 μm. e Pathological score of tubular damage (n= 4). f Blood
samples were collected for measurements of serum creatinine (n= 4). g Representative immunoblot of KIM1. h Densitometry of KIM1 signals (n= 4).
The KIM1 signals were normalized to the cyclophilin B signal of the same samples to determine the ratios. The ratios of sham-operated WT were
arbitrarily set as 1. Each symbol (circle and diamond) represents an individual mouse. Error bars: SEM. **p < 0.01
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Fig. 4 BNIP3 deﬁciency increases tubular cell apoptosis after renal IR injury. BNIP3-KO and WT mice were subjected to renal IR or sham
operation (sham). a Representative images of TUNEL staining of kidney tissues. Bar: 75 μm. b Quantiﬁcation of TUNEL-positive cells in kidney tissues,
n= 3. c Representative images of histochemical staining of activated caspase-3 in kidney tissues. Bar: 200 μm. d Quantiﬁcation of activated caspase-3-
positive cells in kidney tissues, n= 3. Each symbol (circle and diamond) represents an individual mouse. Error bars: SEM. **p < 0.01
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Fig. 5 Bnip3 deﬁciency enhances inﬂammation response in kidney following renal IR. Bnip3-KO and WT mice were subjected to renal IR or
sham operation (sham). Kidney tissues were collected for analysis of renal inﬁltration of macrophages and neutrophils, and for measurement of the
mRNA levels of inﬂammatory cytokine IL-1b and TNF-α. a Representative images of macrophage and neutrophil staining. Bar: 50 μm. b Quantitation
of macrophage-positive cells (n= 4). c Quantitation of neutrophil-positive cells. d Relative change of Il-1b transcript levels in kidney tissues (n= 3). e
Relative change of Tnf-α transcript levels in kidney tissues (n= 3). The mRNA level of Il-1b and Tnf-α was normalized to the mRNA level of Gapdh in
the same sample to determine the ratios, and the ratios of sham-operated WT were arbitrarily set as 1. Each symbol (circle and diamond) represents
an individual mouse. Error bars: SEM. **p < 0.01; ***p < 0.001
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Fig. 6 Bnip3 deﬁciency accumulates damaged mitochondria and ROS production following renal IR. Bnip3-KO and WT mice were subjected to
renal IR or sham operation (sham). Renal cortex was ﬁxed and processed for TEM analysis and DHE staining. a Representative TEM images of
mitochondrial morphology in proximal tubular cells. b Percentage of abnormal mitochondria (swollen with evidence of severely disrupted cristae
over all mitochondria) (n= 4). c Representative images of DHE staining. DHE nuclear staining indicates the presence of reactive oxygen species (ROS)
(n= 4). Scale bar: 100 μm. d Quantiﬁcation of DHE ﬂuorescence intensity. Each symbol (circle and diamond) represents an individual mouse. Error
bars: SEM. **p < 0.01; ***p < 0.001
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BNIP3 has recently been recognized as a regulator of
mitophagy24,25, but its pro-mitophagy function in kidney
remains largely unknown. In present study, several lines
of evidence supported an occurrence of BNIP3-mediated
mitophagy in renal tubular cells in ischemic AKI, which
includes: (1) upregulation of BNIP3 was associated with
an increase of autophagy ﬂux and mitochondrial proteins
degradation, as well as mitophagosome formation in renal
tubular cells following renal IR (Figs. 2 and 7); (2) all of
these above changes were partially reversed by loss of
BNIP3 (Figs. 2 and 7); (3) loss of BNIP3 led to the accu-
mulation of damaged mitochondria following renal IR
(Fig. 6). Of note, recent studies from us and others have
demonstrated an induction of PINK1-PARK2 pathway of
mitophagy in RPTCs during AKI17–19. Collectively, these
ﬁndings strongly support an involvement of mitophagy in
AKI pathogenesis, and, moreover, mitophagy in AKI may
involve multiple pathways. Recent studies also provide
evidence that there exists cross-talks between different
mitophagy pathways. For instance, in cardiac myocytes,
PARK2 translocation to mitochondria was demonstrated
to be essential for BNIP3-mediated mitophagy35. More
recently, Zhang et al.24 provided evidence that BNIP3
binding to PINK1 suppressed PINK1 proteolytic cleavage
and therefore increased the accumulation of intact PINK1
on the outer membrane of mitochondria, leading to
increased PARK2 recruitment to the mitochondria and
consequent mitophagy induction. Thus, it will be inter-
esting to investigate whether BNIP3 and PINK1/PARKIN
pathways of mitophagy act coordinately in regulating
renal tubular cell mitophagy in AKI.
Mitophagy is a critical component of the mitochondrial
quality control, which is critical for the maintenance of a
healthy mitochondrial population and thereby cell viabi-
lity. Under conditions when damaged mitochondria
overwhelm the capacity of mitophagy, and/or mitophagy
is impaired, damaged mitochondria accumulate, which
may result in excessive ROS production, activation of cell
death, and release of mitochondrial DAMPs. In consistent
with previous reports, we veriﬁed that renal IR induced
mitochondrial damage and increased ROS production in
renal tubular cells, and, more importantly, these changes
were aggravated within kidneys of Bnip3-KO mice in the
same experiment (Fig. 6). It is conceivable that failing of
BNIP3-mediated mitophagy expands renal IR-induced
mitochondrial damage, which leads to further damage to
the mitochondria and ultimately irreversible cell injury
and cell death. Moreover, ROS, mitochondrial DAMPs,
and various factors or contents released from necrotic
tubular cells may stimulate robust inﬂammation to con-
tribute tissue damage. In line with this notion, renal IR
induced a stronger inﬂammatory response in the kidney of
BNIP3-KO mice than in WT mice, as evidenced by sig-
niﬁcantly more macrophage and neutrophil inﬁltration
into kidneys and higher expression of proinﬂammatory
cytokines in these KO mice compared to WTmice (Fig. 5).
In summary, this study has provided substantial evi-
dence for the activation of BNIP3-mediated mitophagy in
RPTCs in ischemic AKI. We provided further evidence
that BNIP3-mediated mitophagy has important role in
mitochondrial quality control, tubular cell survival, and
renal function during AKI. Notably, previous reports
suggest that induction of PINK1/PARKIN pathways of
mitophagy protects against AKI. As such, enhancing
mitophagy may offer a novel therapeutic strategy for AKI.
Material and methods
Cells, plasmids, and transfection
BUMPTs were originally from Dr. Wilfred Lieberthal
(Boston University School of Medicine) and maintained as
described previously36. Bnip3-KD cells were generated by
infection of BUMPT cells with Bnip3-shRNA-encoding
lentivirus. Brieﬂy, shRNAs speciﬁcally targeting mouse
Bnip3 were synthesized by GenePharma (China), and then
inserted into lentivirus vector PLKO.1 (Addgene plasmid
#8453). After viral packaging, the viruses encoding Bnip3
shRNA were harvested to infect BUMPT cells. Infected
cells were selected with 2.5 mg/ml puromycin (Sigma-
Aldrich) to generate stable cell line with Bnip3 KD. The
KD efﬁciency was determined by qRT-PCR and immu-
noblotting analysis. The shRNA target sequences of Bnip3
were as follows: forward, 5′-CAGCCTCCGTCTCTA
TTTA-3′; reverse, 5′-TACCAACAGAGCTGAAATA-3′.
The GFP-LC3B plasmid was obtained from Addgene
(#11546). Transfections of BUMPT cells with plasmid
DNAs were performed by using Lipofectamine 3000
(see ﬁgure on previous page)
Fig. 7 Bnip3 deﬁciency suppresses renal IR-induced mitophagy. Bnip3-KO and WT mice were subjected to renal IR or sham operation (sham).
Renal cortex was collected for immunoblot analyses of LC3B-I/II, SQSTM1, TIMM23, and cyclophilin B (loading control), immunoﬂuorescence of LC3B
and COXIV, and for transmission electronic microscopy (TEM) analysis. a Representative blots. b–d Densitometry of LC3B-II (b), SQSTM1 (c), and
TIMM23 (d). For densitometry, the target proteins signals were normalized to the cyclophilin B signal of the same samples to determine the ratios,
and the ratios of sham-operated WT were arbitrarily set as 1 or 100%. e Representative images of immunoﬂuorescence staining of LC3B (green) and
COXIV (red) and DAPI (blue). f Percentage of renal tubules with LC3B puncta. g Percentage of renal tubules with mitophagosome formation (LC3B
puncta colocalizes with mitochondria) in renal tubules. Bar: 50 μm. h TEM images of mitophagosome (pointed by arrowhead in the right panel)
in renal proximal tubule cells after IR. Each symbol (circle and diamond) represents an individual mouse. Error bars: SEM, n= 3. *P < 0.05; **p < 0.01;
***p < 0.001
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reagents (L3000008; Thermo Fisher Scientiﬁc) under the
manufacturer’s instruction.
Antibodies and reagents
Anti-SQSTM1 (5114), anti-COXIV (11967), and anti-
activated caspase-3 (9664) were from Cell Signaling
Technologies; anti-LC3B (NB100-2220) were from Novus
Biologicals; anti-TIMM23 (sc-514463) and anti-TOMM20
(sc-11415) were purchased from Santa Cruz Biotechnol-
ogy; anti-KIM1/HAVCR1 (hepatitis A virus cellular
receptor 1) from R&D Systems; anti-cyclophilin B, anti-
macrophage (RM0029-11H3), anti-neutrophil (NIMP-
R14), and anti-BNIP3 (ab109362, ab10433) were obtained
from Abcam; anti-β-actin (A5316) was from Sigma-
Aldrich. All secondary antibodies, DHE (D11347) and
collagen I (A1048301), were purchased from Thermo
Fisher Scientiﬁc, and TUNEL assay kit (12156792910) was
obtained from Roche Life Science.
Oxygen-glucose deprivation-reperfusion
OGD-R in BUMPT cells was performed as previously
described with modiﬁcation37. Brieﬂy, BUMPT cells were
seeded in collagen I-coated plates at 24 h before treatment.
Cells at an ~95% conﬂuence were rinsed once with glucose-
free Dulbecco’s modiﬁed Eagle’s media (Thermo Fisher Sci-
entiﬁc, 11966), and then maintained in both O2 and glucose-
free medium. Cells were immediately placed in a sealed
incubator chamber (Billups-Rothenburg, MIC-101), and then
loaded with N2 gas for 10min at 25 L/min. After incubation
at 37 °C for 2 h, cells were transferred back to normal culture
medium and regular incubator with oxygen for reperfusion.
Cells cultured in normal medium and regular cell incubator
with 21% oxygen were used as control.
Animals and renal IR
Animal experiments were conducted in accordance
with a protocol approved by the Institutional Animal Care
and Use Committee of the Second Xiangya Hospital of
Central South University. C57BL/6 mice were purchased
from SJA Laboratory Animal Corporation (Hunan,
China). Bnip3-KO mice were previously described24. Mice
were housed in a pathogen-free condition under cycles of
12:12-h light and dark with free access to food and water.
Renal IR surgery in mice was performed as previously
described18. Brieﬂy, bilateral renal pedicles were exposed
for clamping to induce 30min of ischemia, and the
clamps were then released for reperfusion for 48 h. Mice
underwent the same operation without renal pedicle
clamping were as sham control mice.
Renal function and histopathology
Serum creatinine was evaluated to determine renal func-
tions with a kit from BioAssay Systems (DICT-500) as pre-
viously described18. To determine tissue damage, parafﬁn-
embedded kidney tissue sections with a thickness of 4 µm
were stained with HE. Renal tubules with loss of brush
border, tubular dilation and disruption, cast formation, and
cell lysis were considered damaged. Tissue damage was
evaluated by the percentage of damaged tubules: 0, no
damage; 1, <25%; 2, 25–50%; 3, 50–75%; 4, >75%.
Immunohistochemical analysis
Immunohistochemical staining was performed as
described in our recent studies18. Brieﬂy, parafﬁn-
embedded kidney sections were sequentially underwent
deparafﬁnization, hydration, and antigen retrieval by
incubation with 0.1M sodium citrate, pH 6.0 at 100 °C.
After subsequent incubation in 3% H2O2, 5% normal
donkey serum and 0.1% Triton X-100 to reduce non-
speciﬁc binding, tissue sections were exposed to 1:100
anti-BNIP3 (Abcam, Ab10433), 1:200 anti-cleaved cas-
pase-3 (5A1E) (Cell Signaling, 9664), 1:100
anti-macrophage (Abcam, RM0029-11H3) or 1:100 anti-
neutrophil (Abcam, NIMP-R14) at 4 °C overnight fol-
lowed by exposure to horseradish peroxidase (HRP)-
conjugated secondary antibody for 1 h at room tempera-
ture. Signals of the antigen–antibody complexes were
detected with a DAB Peroxidase Substrate Kit (Vector
Laboratories) following the manufacturer’s introduction.
Sections were then counterstained with DAPI (4′,6-dia-
midino-2-phenylindole) (Sigma-Aldrich, D9542). For
quantiﬁcation, 10–20 ﬁelds were randomly selected from
each tissue section and the amounts of positive cells per
mm2 was evaluated.
TUNEL assay
TUNEL assays were performed to evaluate cell apop-
tosis in kidney tissue and BUMPT cells using an In Situ
Cell Death Detection Kit (Roche Applied Science, India-
napolis, IN) as described in our recent studies29,38. For
quantiﬁcation, the number of TUNEL-positive tubular
cells in kidney sections in at least 10 optical ﬁelds in each
tissue section from three different kidneys per group was
counted, and the amount of TUNEL-positive cells per
mm2 was evaluated. For quantiﬁcation of TUNEL-positive
BUMPT cells, at least 10 optical ﬁelds with >200 cells
from three different experiments were examined in each
condition to estimate the apoptosis percentage.
Determination of ROS
DHE staining of frozen kidney tissues were performed
to elevated ROS levels as previously described18. Brieﬂy,
after harvest, kidney tissues were immediately placed in
Tissue-Tek optimal cutting temperature compound
(Sakura Finetek, 4583), followed by snap freezing in liquid
nitrogen. Unﬁxed frozen kidney sections of 20 μm thick-
ness were incubated in 10 μM DHE at 37 °C for 30 min
followed by counterstaining with DAPI (Sigma-Aldrich,
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D9542). Samples were imaged with confocal microscopy
(Leica, TCS SP5). For quantiﬁcation, the ﬂuorescent
density in the nuclei of proximal tubular cells within 10
random optical ﬁeld from three different kidneys per
group was determined with the ImageJ software.
Transmission electron microscopy
TEM analysis was performed as recently described29.
Immediately after harvest, kidney tissues were sequen-
tially ﬁxed in paraformaldehyde and glutaraldehyde
(Sigma-Aldrich, 340855), post ﬁxation in osmium tetra-
oxide (Sigma-Aldrich, 201030), and dehydration in etha-
nol. Samples were then embedded in Epon (Sigma-
Aldrich, 45345). Seventy-nanometer-thick tissue sections
were stained with uranyl acetate (TED PELLA, 19481) and
lead citrate (Sigma-Aldrich, 15326). Samples were imaged
by using the TEM (Leica). For quantiﬁcation of abnormal
mitochondria that were swollen with severely disrupted
cristae, at least 400 individual mitochondria from four
different kidneys per group were counted. The percentage
of abnormal mitochondrial over all mitochondria was
analyzed to indicate the degree of mitochondrial damage.
Quantitative real-time PCR
Total RNA from cells and kidney tissues was extracted
with TRIzol reagent (Thermo Fisher Scientiﬁc, 15596026)
according to the manufacturer’s instruction. Com-
plementary DNA was synthesized using reverse tran-
scription reagents (Thermo Fisher Scientiﬁc, N8080234).
Quantitative real-time PCR was performed with the TB
Green Premix Ex Taq II reagent (TaKaRa, RR820B) on
LightCycler96 Real-Time PCR System (Roche Life Sci-
ence). For quantiﬁcation, the mRNA levels of target genes
were normalized to the mRNA levels of Gapdh. Primers
used were as follows: Bnip3—forward, 5′-GCTCCCAG
ACACCACAAGAT-3′ and reverse, 5′-TGAGAGTAG
CTGTGCGCTTC-3′; Tnf-α—forward, 5′-CAGGCGGTG
CCTATGTCTC-3′ and reverse, 5′-CGATCACCCCGAA
GTTCAGTAG-3′; Il-1b—forward, 5′-GAAATGCCACC
TTTTGACAGTG-3′ and reverse, 5′-CTGGATGCTCT-
CATCAGGACA-3′; Gapdh—forward, 5′-AGGTCGGT
GTGAACGGATTTG-3′ and Gapdh reverse, 5′-GGG
GTCGTTGATGGCAACA-3′.
Immunoﬂuorescent staining
Immunoﬂuorescence staining in cultured cells was
performed as previously described24. Brieﬂy, cells were
washed once with phosphate-buffered saline (PBS), fol-
lowed by ﬁxation with 4% paraformaldehyde and sub-
sequent permeabilization with 0.1% Triton X-100. After
being blocked with 5% bovine serum albumin, cells were
probed with 1:100 anti-LC3B and 1:100 anti-COXIV,
followed by exposure to Alexa-conjugated secondary
antibodies. Samples were imaged using a confocal
microscope (Leica, TCS SP5). For quantiﬁcation, the
number of LC3B puncta and LC3B puncta colocalizing
with the mitochondria from at least 30 cells in three
independent experiments were counted. For immuno-
ﬂuorescence staining in kidney tissues, paraﬁlm-
embedded tissue sections underwent deparafﬁnization,
rehydration, and antigen retrieval by incubation with
1 mM EDTA (pH 8.0) at 95–100 °C for 1 h. After being
subsequently incubated with 3% H2O2, 5% normal donkey
serum, and 0.1% Triton X-100. Sections were exposed to
primary antibodies at 4 °C overnight and detected with
Alexa-conjugated secondary antibodies. Samples were
imaged using a confocal microscope (Leica, TCS SP5). For
quantiﬁcation, the number of LC3B puncta and LC3B
puncta colocalizing with mitochondrial signals from 10 to
20 random ﬁelds (×400) for each slide from three different
kidneys was counted to indicate autophagosome and
mitophagosome formation.
Immunoblot analysis
Cells or kidney tissues were washed with PBS buffer and
then lysed in sodium dodecyl sulfate (SDS) sample buffer
(63 mM Tris-HCl, 10% glycerol, and 2% SDS) containing
protease inhibitor cocktail (Sigma-Aldrich). Protein con-
centration was determined by the BCA method with
reagents from Thermo Scientiﬁc. Equal amount of pro-
teins from different groups were separated by electro-
phoresis. After transferring onto polyvinylidene diﬂuoride
membrane, the membrane was sequentially incubated
with blocking buffer (5% skim milk), a primary antibody
and a corresponding HRP-linked secondary antibody. The
target protein was visualized using chemiluminescent
substrate (Thermo Scientiﬁc). The protein band intensity
was quantiﬁed by the ImageJ software (NIH).
Statistical analysis
Statistical analysis was conducted with the Prism soft-
ware (GraphPad). Statistical differences in multiple
groups were determined by multiple comparisons with
analysis of variance, followed by Tukey’s post tests. Dif-
ferences between two groups were determined by two-
tailed unpaired or paired Student’s t test. Quantitative
data were expressed as means ± SEM.
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